Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
(Stockholm 24 January, 2020) Inhalation Sciences (ISAB) has signed a CRO (Contract research) order worth 750 KSEK with a returning customer who has carried out extensive previous CRO with ISAB, and purchased ISAB lab systems.
The total value of the order is 1.1 MSEK. 750 KSEK is for services provided by ISAB, and the remaining 350 KSEK to other research companies collaborating on the project. This CRO will employ ISAB's novel in vitro simulation tool DissolvIt, and its IPL (Isolated Perfuse Lung) module.
ISAB CEO Manoush Masarrat "When clients of this calibre return time and again, it shows that the data we deliver quite simply puts them in the lead."
"2020 is planned to be a breakthrough year for DissolvIt, and this is a fantastic start. DissolvIt's IVIVC (In Vitro In Vivo Correlation) capabilities are leading, generating vital data, including Cmax and Tmax curves, that until now have not been able to be captured using conventional in vitro and in vivo experiments. This year we will see that awareness of DissolvIt will increase as we see the module up and running in commercial labs generating credible, repeatable IVIVC data. This is an excellent start to 2020!"